OTLK - Outlook Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 0.42		 Change
 ⇑ +0.02   (+0.00%)		 Volume
  1,720,127
Open
 0.40		 High
 0.46		 Low
 0.40
8EMA (Daily)
 0.43		 40EMA (Daily)
 0.82		 50EMA (Daily)
 0.92		 STO (Daily)
 13.750		 MACD Hist (Daily)
 0.038
8EMA (Weekly)
 0.747		 40EMA (Weekly)
 1.58		 50EMA (Weekly)
 1.92		 STO (Weekly)
 1.512		 MACD Hist (Weekly)
 -0.140
Company Profile
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com